SCHEMBL24319629

SCHEMBL24319629

CC1CC(N(C)CC2CCNCC2)C1

nearest known ligand 0.34

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ADRA1B P35368 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5645558 0.84 NOS3 (0.33) ADRA1B
SCHEMBL25565965 0.84 NOS3 (0.36) ADRA1B
SCHEMBL27391655 0.82 NOS3 (0.35) ADRA1B
SCHEMBL24320683 0.80 TDP1 (0.32)
SCHEMBL3473819 0.79 SLC6A2 (0.37) ADRA1B
SCHEMBL5651239 0.78 ADRA1B (0.39) ADRA1B
Hydrochloric Acid SCHEMBL3474532 0.78 SLC6A2 (0.36) ADRA1B
SCHEMBL24319183 0.76 NCF1 (0.41) ADRA1B
SCHEMBL12717990 0.76 NCF1 (0.41) ADRA1B
SCHEMBL27564858 0.74 ADRA1B (0.42) ADRA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022047145-A1 RAPIDLY ACCELERATING FIBROSARCOMA PROTEIN DEGRADING COMPOUNDS AND ASSOCIATED METHODS OF USE ARVINAS OPERATIONS, INC. (US) 2022-03-03 WO disclosed